NICE: 2000/015
Issued: 23 May 2000
PRESS RELEASE
NICE ESTABLISHES GUIDELINES ADVISORY COMMITTEE
The National Institute for Clinical Excellence has established a Guidelines Advisory Committee to advise the Institute on the development of clinical guidelines.
The twenty-four strong committee, chaired by Professor Martin Eccles, consists of experts from the health professions, patient organisations, health economists and NHS management.
The committee will meet six times a year and its role will include advising on commissioning briefs, signing off completed guidelines, advising on audit benchmarks and giving advice on the audit methodologies underpinning the guidelines.
Professor Peter Littlejohns, Clinical Director said: "Clinical guidelines are one of the ways in which the Institute can work with health professionals and patients to improve the quality and consistency of care provided by the NHS. The Guidelines Advisory Committee will provide robust, expert and objective advice in the development of our guidelines."
"It will have a key role working to shape the Institute's clinical guidelines to provide authoritative advice to patients and the NHS". Members of the new committee are attached on Appendix A and the Terms of Reference are set out in Appendix B.
Ends
Anne-Toni Rodgers
Communications Director
Appendix A
Guidelines Advisory Committee Members
Stephanie A Amiel, BSc, MD, FRCP
RD Lawrence Professor of Diabetic Medicine, Kings College
I am a Professor of Diabetic Medicine at King's College (Guy's, King's and St Thomas' School of Medicine), with an Honorary Consultant Contract at King's College Hospital. My current clinical practice is exclusively in Diabetes, but I am also a General Physician and my previous appointment included an Honorary Consultant Contract at Guy's with responsibility for acute general medicine including takes. I also ran the Endocrine clinic there with a colleague. Both this and my current post have involved the development of guidelines for diabetes and endocrine disease, both in-house and in collaboration with primary care colleagues. My academic expertise is in intensified diabetes therapy (which reduces risk of chronic complications) and specifically acute hypoglycaemia, the principle short-term complication of drug therapy for diabetes.
Mr. Charles Collins
Consultant General Surgeon, Taunton
Charles Collins has been a Consultant General Surgeon with a special interest in Coloproctology in Taunton since 1973 and was Medical Director of the Taunton and Somerset Trust from 1991-1995. In 1989 he was elected Regional Adviser in Surgery to The Royal College of Surgeons, a post he held until 1995. During the 1980s he was Chairman of the Regional Surgical Advisory Committee and for several years was Chairman of the Regional Surgical Training Committee. From 1993-1998 he was on the Specialist Advisory Committee (SAC of General Surgery) and latterly was the Vice Chairman. IN 1995 he was elected to the Council of The Royal College of Surgeons and has been Chairman of the College's Higher Surgical Training Committee, the Committee on Clinical Effectiveness and the Patient Liaison Group. He was a member of the Academy of Medical Royal Colleges Working Party on Accreditation of Hospital Services and is now a member of the RCS Professional Standards Committee. He has written several policy documents for the College and responses to for example the Bristol Public Enquiry and the NHS rationalization task forces, and is currently involved as a member of the Professional Standards Committee in developing a process for the re-validation of surgeons. He has been Adviser in General Surgery to the Chief Medical Officer for the past two years. In recent years he has published several publications on hospital practice.
Joyce Cormie
Consumer Representative
Most of Joyce's later life has been involved with elderly people, firstly with a council of voluntary service and latterly with Age Concern Scotland. I set up community dementia teams throughout Fife to ensure that work in this field would be more co-ordinated. In 1992, as a consequence of the NHS and Community Care Act of 1990, the then Assistant Director of Age Concern Scotland and I started the innovative work of the Fife User Panels Project. This work brings together, on a regular basis, very frail, older people who live in their own homes and enables them to have a say in how services currently, and in the future, should develop. It has proved a very successful example of good working practice. I led this work from its inception until I felt Age Concern Scotland in 1998.
Professor Mike Drummond
Director, Centre for Health Economics (CHE) University of York
Mike is Professor of Economics and has been Director of the Centre since December 1995. His particular field of interest is in the economic evaluation of health care treatments and programmes. He has undertaken evaluations in a wide range of medical fields including care of the elderly, neonatal intensive care, immunisation programmes, services for people with AIDS, eye health care and pharmaceuticals.
Vice Chair: Professor Gene Feder
St Bartholomews and the Royal London School of Medicine & Dentistry
Gene Feder is Professor of Primary Care Research and Development at St Bartholomew's
and the Royal London School of Medicine & Dentistry at Queen Mary and Westfield
College and a part-time GP principal in Hackney, East London. His expertise
includes clinical guidelines development & implementation and his research interests
include chronic disease management in primary care and at the primary/secondary
care interface, prevention of falls in the elderly, management of domestic violence
and evaluation of innovations in general practice.
Chairman: Professor Martin Paul Eccles MD, FRCP, FRCGP, MFPHM
Professor of Clinical Effectiveness, Centre for Health Services Research, University of Newcastle upon Tyne Professor Eccles is Professor of Clinical Effectiveness at the Centre for Health Services Research, University of Newcastle upon Tyne. He is a research director running a programme of research into 'Effective Professional Practice' within which he runs the North of England Evidence Based Guideline Development Programme. He also works one day a week as a general practitioner in Northumberland. He is a member of the NHS R&D Health Technology Assessment Commissioning Panel and a member of the NHS R&D 'Methods to promote the uptake of research findings' Research Commissioning Panel.
David Edwards
Chief Executive, University Hospital of Wales and Llandough Hospital NHS
Trust
Mr. Edwards was newly appointed as the Chief Executive of the University Hospital of Wales and Llandough Hospital NHS Trust on 1st November 1999 and has subsequently been appointed as the Chief Executive of the new Cardiff and Vale NHS Trust with effect from 1st April 2000. This follows the merger of the University Hospital of Wales and Llandough Hospital NHS Trust with the Cardiff and District Community NHS Trust on that date. Mr. Edwards has 31 years NHS experience following 8 years working for British Steel and GKN. He was previously the Chief Executive at Queens Medical Centre in Nottingham for 9 years and before that was District General Manager at Central Birmingham Health Authority. He has worked in the Community, in hospitals, at Health Authority and Regional level, specialising in teaching environments and the management of change. He is a highly respected senior NHS manager and holds many national and regional roles, including membership of the NHS Confederation National Council.
Professor Jeremy Grimshaw
Professor Jeremy Grimshaw trained as a general practitioner. He has undertaken systematic reviews of methods to implement clinical guidelines, methodological studies of how best to develop and appraise valid guidelines and rigorous studies of the guideline implementation strategies. He is the Co-ordinating editor of the Cochrane Effective Practice and Organisation of Care Review Group. He is currently a Professor of Health Services Research and Programme Director in the Health Services Research Unit and is responsible for the largest programme of implementation research in the United Kingdom. He is also the Methodological Adviser to the Scottish Intercollegiate Guidelines Network.
Gill Harvey
Head of Quality Improvement, RCN
I am Head of Quality Improvement at the RCN, where I have responsibility for a programme of work on clinical effectiveness, national clinical guidelines, audit, clinical governance and quality improvement. Recently, we have been undertaking work on the development of three national clinical guidelines (venous leg ulcers, pain assessment in children and the assessment and prevention of pressure ulcers) and are co-ordinating a national sentinel audit of venous leg ulcers to facilitate and evaluate the implementation of the guideline in practice. I am an Associate Editor of the journal Quality in Health Care and currently co-chair of the European Forum for Quality Improvement in Healthcare.
Dr Bernard Higgins
Consultant Chest Physician, Newcastle upon Tyne
My background is in Respiratory Medicine: currently Consultant Physician at the Freeman Hospital, Newcastle upon Tyne. My Guideline expertise comes from having collaborated in the production of the North of England Evidence-based Asthma Guidelines, and more recently as Chairman of the British Thoracic Society's Standards of Care Committee which is responsible for a variety of established clinical Guidelines.
Professor Allen Hutchinson
Director, Public Health Section, ScHARR, University of Sheffield;
I am a guideline methodologist with a background in general practice and public health. I am currently working on major depression and type 2 diabetes and have experience in developing multi-college guidelines.
Dr Marcia Kelson
Senior Researcher, College of Health
Marcia is Senior Research Fellow at the College of Health, a national charity that aims to promote patient interests in the NHS. Her particular area of interest is patient, carer and public involvement in clinical audit and guideline development and she is the author of several policy and practical guidance documents on patient involvement. She has been a consumer representative on guideline development teams and was consumer advisor to the NICE Referral Protocols Project. She is currently consumer advisor to NICE's guideline programme and is an advisor to the Commission for Health Improvement. Marcia is also a non-executive director of the West Middlesex NHS Hospital Trust.
Dr Fergus Macbeth
Director, Clinical Effectiveness Support Unit (Wales)
I am a Consultant Oncologist with an interest in lung cancer and, since 1996, I have also been Director of the Clinical Effectiveness Support Unit (Wales). I have chaired two guideline development groups, first of all for SIGN and then for the Royal College of Radiologists' COIN project, both of which have produced evidence-based guidelines on the management of lung cancer. I was also on the Editorial Advisory Board of the NHS Executive's Guidance on Lung Cancer, published in 1998.
Dr James Mason
Senior Research Fellow, Centre for Health Economics, University of York
Recent work has included the development of a methodological framework for incorporating economics in guidelines and participation in a series of North of England and Royal College guidelines. Earlier work included health economics input for the first series of Effective Health Care Bulletins and development of the prototype Department of Health Register of Cost Effectiveness Studies.
Judy Mead
Head of Clinical Effectiveness, Chartered Society of Physiotherapy;
Judy is a chartered physiotherapist who has responsibility for developing the Society's strategic approach to clinical effectiveness and implementing work programmes relating to clinical effectiveness, clinical audit, clinical guidelines, outcome measures, clinical governance and quality improvement. She led the introduction of the Society's clinical guidelines endorsement process in 1998 and managed the recently completed national sentinel audit on the collaborative, rehabilitative management of elderly people who have fallen. As a physiotherapist working in the NHS, she worked with, and managed services for, elderly people. She subsequently became Regional Audit Co-ordinator for Oxford Region and was involved in establishing the Critical Appraisal Skills Programme. Judy was instrumental in the setting up of the Clinical Effectiveness Forum for Allied Health Professions and remains an active member.
Juliet Miller
Head of SIGN Secretariat
As head of the Scottish Intercollegiate Guidelines Network (SIGN), Juliet has experience in co-ordinating the development, dissemination, and review of the SIGN programme of over 60 evidence-based clinical guidelines for the NHS in Scotland.
Dr Chaand Nagpaul
Dr Chaand Nagpaul is a GP practising in a four-partner group practice in Stanmore, Middlesex. He is currently Chair of the Harrow East & Kingsbury Primary Care Group. He is a member of the BMA's General Practitioners Committee (GPC) and its prescribing sub-committee. He is also a member of the Royal College of General Practitioners Council, and a national executive member of the NHS Alliance.
Professor Robert Shaw
President, The Royal College of Obstetrics and Gynaecology.
Professor Shaw has been responsible for overseeing the development of guidelines in the RCOG for the past ten years. He introduced and developed the College based 'Green Top' Guidelines. He was responsible for securing NHS funds to establish the National Evidence based Guidelines Programme in the College. He has acted as Chairman of the Guidelines Development Group and as Chairman of two National Evidence Based Guidelines. He was responsible for establishing the Clinical Effectiveness and Standards Board within the College and for coordinating Regional National Audits.
Helen Spiby
Senior Lecturer (Evidence Based Practice in Midwifery), Mother and Infant
Research Unit, University of Leeds.
Helen Spiby is a midwife with experience in clinical practice, research and Supervision of Midwifery. Helen has been involved in the development, implementation and evaluation of evidence- based guidelines for care in labour. Helen's post, which is jointly supported by The Leeds Teaching Hospitals NHS Trust, includes a continuing involvement in the development of evidence-based guidelines and the use of these in practice.
Dr Jenny Tyrrell
General Paediatrician
A general paediatrician working in a large DGH with responsibilities for neonates as well as general paediatrics. I have a special interest in respiratory disease and cystic fibrosis. I am responsible for the South and West region cystic fibrosis database. I have been involved in auditing the use of Pulmozyme for these patients and feel very frustrated by 'post code prescribing' so am very pleased that NICE has been established to guide clinicians when prescribing expensive therapy.
Dr John Young
Medical Director, MSD
John qualified in medicine at St. Thomas's, trained in metabolic medicine and chemical pathology. He joined the pharmaceutical industry over 20 years ago and has been Medical Director of Merck Sharp & Dohme since 1986. Areas of expertise include clinical trial design, implementation and trial audits, good clinical practice and pharmacovigilance.
Carol Youngs
Assistant Director, Contact a Family
Carol is paediatric nurse and health visitor by profession. She has worked for the past eleven years for Contact a Family, a national charity working for families caring for children with a wide range of disabilities and special health care needs. Her interest in the particular problems of those affected by rare disorders has led to the formation of the Rare Disorder Alliance -UK a nation wide patient association. She represents national patient associations on the National Screening Committee, Sub Group for Child Health and currently holds the post of Vice President of the European Organisation for Rare Disorders (EURORDIS).
Fiona Wise
Chief Executive, Enfield Community Care Trust Enfield Community Care Trust
Fiona provides a range of services - acute and rehabilitation for the elderly, community, learning difficulties, para-medical and mental health services including forensic psychiatry. During the last year Fiona has been Project Director of the Broadmoor Integration Project. Fiona was until recently Chair of the NHS Confederation Mental Health Advisory Group and was a member of Ministers Independent Reference group for Mental Health and the external Reference Group for Mental Health NSF. Chair of the National Psychotherapy Advisory Group.
Amanda Woodcock
Clinical Manager, Molnlycke Healthcare Ltd;
I am Clinical Manager for Mölnlycke Health Care Ltd; primarily responsible for our wide range of wound care products. As a graduate in physiology, I entered the pharmaceutical industry twelve years ago to work mostly within clinical research, following an initial grounding as a sales representative. I have conducted research projects within a wide range of therapeutic areas including HIV, reproductive endocrinology, diabetes and oncology. Moving to the medical devices industry nearly 3 years ago has added a different aspect to my clinical experience. As well as the clinical development of new wound care products, I am responsible for education and training, UK regulatory and quality assurance and liaison with the Department of Health Drug Tariff section for the inclusion of products on prescription. During this time it has become most apparent that there remain fundamental differences between the development processes for pharmaceuticals and medical devices that require individual approaches from those who wish to conduct product evaluations and assess the outcomes.
Appendix B
Terms of Reference for the Clinical Guidelines Advisory Committee
- to advise on guideline commissioning briefs
- to advise on the establishment and membership of Guideline Advisory Committee Working Groups
- to advise, informally and formally, on matters relating to the production of guidelines, including guideline methodology and monitoring of the guideline development process, the Head of Clinical Guidelines and Audit, the Clinical Director, and the Board
- to advise the Board on user and patient information to accompany the completed clinical guideline
- to advise on audit methodologies that would assist health professionals to monitor their adherence to the Institute's guidelines
- to sign off (after completion of the validation process) completed clinical guidelines. This would include resolving tensions and disagreements between authors, appraisers and other interested parties
- to consider appeals from interested parties against the advice contained within individual clinical guidelines on grounds of either failure of 'due process' or that the guidelines are perverse.
- to advise on dissemination and implementation of clinical guidelines and associated audit methodologies
